tosufloxacin has been researched along with Cystitis in 3 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effectiveness of a single 300-mg dose of tosufloxacin and of 3-day treatment with tosufloxacin (300 mg daily) were compared in a prospective trial in order to clarify the cost-effectiveness of tosufloxacin for acute uncomplicated cystitis." | 7.68 | [Single-dose treatment of tosufloxacin (TFLX) for acute uncomplicated cystitis]. ( Endou, K; Goto, H; Igarashi, H; Kawahara, M; Kiyota, H; Machida, T; Masuda, F; Ohishi, Y; Onodera, S; Suzuki, H, 1992) |
| "The effectiveness of a single 300-mg dose of tosufloxacin and of 3-day treatment with tosufloxacin (300 mg daily) were compared in a prospective trial in order to clarify the cost-effectiveness of tosufloxacin for acute uncomplicated cystitis." | 3.68 | [Single-dose treatment of tosufloxacin (TFLX) for acute uncomplicated cystitis]. ( Endou, K; Goto, H; Igarashi, H; Kawahara, M; Kiyota, H; Machida, T; Masuda, F; Ohishi, Y; Onodera, S; Suzuki, H, 1992) |
| "Tosufloxacin was as effective as levofloxacin when administered twice daily for 2 days as prophylaxis for TBP, which suggests that this regimen is useful for reducing the clinical and febrile infection rate following TBP." | 2.73 | Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin. ( Ishitoya, S; Kamoto, T; Ogawa, O; Okumura, K; Segawa, T; Yamamoto, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, S | 1 |
| Ishitoya, S | 1 |
| Segawa, T | 1 |
| Kamoto, T | 1 |
| Okumura, K | 1 |
| Ogawa, O | 1 |
| Fukushima, S | 1 |
| Moriyama, M | 1 |
| Miyamoto, H | 1 |
| Hosaka, M | 1 |
| Kubota, Y | 1 |
| Kinoshita, Y | 1 |
| Noguchi, K | 1 |
| Shuin, T | 1 |
| Noguchi, S | 1 |
| Yoshimura, S | 1 |
| Kiyota, H | 1 |
| Machida, T | 1 |
| Masuda, F | 1 |
| Ohishi, Y | 1 |
| Onodera, S | 1 |
| Suzuki, H | 1 |
| Goto, H | 1 |
| Kawahara, M | 1 |
| Igarashi, H | 1 |
| Endou, K | 1 |
2 trials available for tosufloxacin and Cystitis
| Article | Year |
|---|---|
Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Cystitis; Fluoroq | 2008 |
[Clinical studies on tosufloxacin (TFLX) in urology].
Topics: 4-Quinolones; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cystitis; | 1992 |
1 other study available for tosufloxacin and Cystitis
| Article | Year |
|---|---|
[Single-dose treatment of tosufloxacin (TFLX) for acute uncomplicated cystitis].
Topics: 4-Quinolones; Acute Disease; Adult; Aged; Anti-Infective Agents; Bacteria; Cystitis; Female; Fluoroq | 1992 |